ABSTRACT
OBJECTIVE: After rhinoplasty, periorbital edema and ecchymosis have been reduced using a variety of techniques. In this research, we assessed the effectiveness of dexamethasone and iridoid in reducing periorbital edema and ecchymosis.
METHODS: Three groups of sixty primary rhinoplasty patients were randomly selected. From the first postoperative day for five days, Group H got hirudoid cream three times daily (POD). Before surgery, group D got 10 mg of dexamethasone intravenously, whereas group C (the control) did not receive any hirudoid or dexamethasone. Two surgeons who were blind to the drugs given on the 2nd, 5th, and 7th PODs evaluated the degree of edema and the severity of the ecchymosis.
RESULTS: Group D exhibited much less edema than groups H and C on the 2nd POD, but there was no appreciable difference between the three groups regarding the extent or severity of ecchymosis. When compared to group C, group H had much less ecchymosis on the seventh POD. Group H performed better than the other groups in terms of the resolution of edema severity and ecchymosis intensity when the difference between the second and seventh PODs was examined (p-value < 0.001).
CONCLUSION: After rhinoplasty, hirudoid has been demonstrated to be beneficial in decreasing edema and ecchymosis. Early postoperative days saw periorbital edema prevention benefits from dexamethasone treatment, but ecchymosis resolution did not improve.
KEYWORDS: edema, hirudoid, rhinoplasty